Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
22 hedge funds and large institutions have $7.65M invested in Neurotrope, Inc. Common in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.
53% more call options, than puts
Call options by funds: $127K | Put options by funds: $83K
51% more capital invested
Capital invested by funds: $5.07M → $7.65M (+$2.57M)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
4% less funds holding
Funds holding: 23 → 22 (-1)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
+$503K |
| 2 |
TCM
Tanaka Capital Management
New York
|
+$277K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$121K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.3K |
| 5 |
BlackRock
New York
|
+$4.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$88.4K |
| 2 |
Bank of New York Mellon
New York
|
-$68K |
| 3 |
VF
Virtu Financial
New York
|
-$65K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18.6K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$14.6K |
NTRP Hedge Fund Activity: Q4 2017 in Review
22 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q4 2017, worth a combined $7.65M — up 51% from $5.07M a quarter earlier.
Fund positioning in NTRP was balanced in Q4 2017: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 7 trimmed.
The largest buyer was Cannell & Co, adding an estimated $503K. The largest seller was Group One Trading, cutting an estimated $88.4K.
- 22 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q4 2017, down from 23 in Q3 2017.
- Funds reported $7.65M of Neurotrope, Inc. Common stock for Q4 2017, up 51% quarter-over-quarter.
- 2 funds opened new Neurotrope, Inc. Common positions in Q4 2017 and 2 closed out, a net change of 0 holders.
- The largest Neurotrope, Inc. Common buyer in Q4 2017 was Cannell & Co, an estimated $503K added.
- The largest Neurotrope, Inc. Common seller in Q4 2017 was Group One Trading, an estimated $88.4K sold.
Based on aggregated 13F filings for Q4 2017.